|
Journal of Lipid Research, Vol 28, 183-194, Copyright © 1987 by Lipid Research, Inc.
Chylomicron remnant-vitamin A metabolism by the human hepatoma cell line HepG2
CM Lenich and AC Ross
The binding and metabolism of [3H]vitamin A-containing chylomicron (CM)
remnants by the human hepatoma cell line HepG2 were studied. Mesenteric
lymph chylomicrons were collected from [3H]retinol-fed rats and incubated
with lipoprotein lipase to obtain CM remnants. At 4 degrees C, specific CM
remnant binding was inhibited by an excess of unlabeled CM remnants.
Specific binding predominated at low concentrations and approached
saturation while total binding continued to increase over an extensive
concentration range (0.45-32 microgram triglyceride/ml). CM remnant uptake
at 37 degrees C was greater than that of CM and at least 70 times more
efficient than the pinocytosis of sucrose. CM remnant binding increased
with the extent of lipolysis. Addition of human apolipoprotein E enhanced
both CM remnant and CM binding. After internalization, HepG2 cells
hydrolyzed CM remnant-[3H]retinyl esters, and radiolabeled metabolites
accumulated. As a function of the concentration of [3H]retinoid initially
bound to cells, retinol and retinyl esters accumulated as the major
cell-associated metabolites. In contrast, retinol was the major metabolite
in the medium only at low retinoid concentrations; other more polar
metabolites accumulated at higher concentrations (greater than 110 pmol
retinoid/mg cell protein). The accumulation in the medium of labeled
metabolites derived from CM remnant-retinoid was reduced when cells were
preincubated in unlabeled retinol-supplemented media. The specific activity
of retinol in the medium indicated that CM remnant-vitamin A had mixed with
the cellular store prior to its secretion as retinol. These results
indicate that HepG2 cells internalize CM remnants in part by specific
binding sites, and that the metabolism of CM remnant-retinoids by the HepG2
cell involves retinyl ester hydrolysis and the secretion of retinol and
other more polar metabolites. These processes were regulated in part by the
concentration of retinoid delivered by the CM remnant and by the initial
retinoid content of the cell.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Casiraghi, M. Garsetti, G. Testolin, and F. Brighenti
Post-Prandial Responses to Cereal Products Enriched with Barley {beta}-Glucan.
J. Am. Coll. Nutr.,
August 1, 2006;
25(4):
313 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Ross, A. M. G. Pasatiempo, and M. H. Green
Chylomicron Margination, Lipolysis, and Vitamin A Uptake in the Lactating Rat Mammary Gland: Implications for Milk Retinoid Content
Experimental Biology and Medicine,
January 1, 2004;
229(1):
46 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Dueker, Y. Lin, B. A. Buchholz, P. D. Schneider, M. W. Lamé, H. J. Segall, J. S. Vogel, and A. J. Clifford
Long-term kinetic study of {beta}-carotene, using accelerator mass spectrometry in an adult volunteer
J. Lipid Res.,
November 1, 2000;
41(11):
1790 - 1800.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. M. van Bennekum, Y. Kako, P. H. Weinstock, E. H. Harrison, R. J. Deckelbaum, I. J. Goldberg, and W. S. Blaner
Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester
J. Lipid Res.,
March 1, 1999;
40(3):
565 - 574.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Lemieux, R. Fontani, K. D. Uffelman, G. F. Lewis, and G. Steiner
Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins
J. Lipid Res.,
October 1, 1998;
39(10):
1964 - 1971.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Lopez-Miranda, J.M. Ordovas, M.A. Ostos, C. Marin, S. Jansen, J. Salas, A. Blanco-Molina, J.A. Jimenez-Pereperez, F. Lopez-Segura, and F. Perez-Jimenez
Dietary Fat Clearance in Normal Subjects Is Modulated by Genetic Variation at the Apolipoprotein B Gene Locus
Arterioscler. Thromb. Vasc. Biol.,
September 1, 1997;
17(9):
1765 - 1773.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Pitha
Amorphous Soluble Cyclodextrins: Pharmaceutical and Therapeutic Uses
Journal of Bioactive and Compatible Polymers,
January 1, 1988;
3(2):
157 - 163.
[Abstract]
[PDF]
|
 |
|
Copyright © 1987 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|